Corporate News 11-Dec-18
Unichem Laboratories receives USFDA tentative approval for Tadalafil Tablets
Unichem Laboratories has received tentative approval for its ANDA, Tadalafil Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg from the USFDA for a generic version of Eli Lilly's Cialis, 2.5 mg, 5 mg, 10 mg and 20 mg.
Previous News
Unichem receives USFDA approval for Quetiapine ER Tablets
( Corporate News - 16-Aug-22 10:50 )
Unichem Laboratories to declare Quarterly Result
( Corporate News - 19-Oct-23 12:22 )
Unichem Laboratories receives ANDA approval for Tolterodine Tartrate Tablets
( Corporate News - 06-Aug-20 14:22 )
Unichem Lab rises on receiving USFDA nod for anticonvulsant drug
( Hot Pursuit - 23-Aug-22 11:20 )
Unichem Laboratories reports consolidated net loss of Rs 11.49 crore in the June 2021 quarter
( Results - Announcements 31-Jul-21 15:01 )
Unichem Labs gets US FDA nod for bipolar treatment drug
( Hot Pursuit - 28-Feb-22 11:58 )
Unichem Lab spurts after turnaround Q4 numbers
( Hot Pursuit - 30-May-22 12:48 )
Unichem Laboratories allots equity shares
( Corporate News - 22-Sep-16 18:25 )
Unichem Lab receives ANDA approval for Divalproex Sodium ER tablets
( Corporate News - 28-Feb-22 12:33 )
Unichem Laboratories gets USFDA approval for Pramipexole Dihydrochloride Tablets
( Corporate News - 21-Dec-18 16:32 )
Board of Unichem Laboratories appoints director
( Corporate News - 20-Mar-23 11:16 )
Other Stories
Gujarat Toolroom to conduct EGM
08-Jul-24 19:53
Macro Intl. to conduct AGM
08-Jul-24 19:52
Ecoboard Industries schedules AGM
08-Jul-24 19:52
Eraaya Lifespaces schedules EGM
08-Jul-24 19:52
Binny to convene EGM
08-Jul-24 19:52
ICRA upgrades long term rating on bank facilities of Keystone Realtors
08-Jul-24 19:17
Sadbhav Engineering schedules EGM
08-Jul-24 19:08
Board of Va Tech Wabag approves divestment of Wabag Romania
08-Jul-24 19:08
Global Capital Markets to announce Quarterly Result
08-Jul-24 19:07
Motherson Sumi Wiring India schedules board meeting
08-Jul-24 19:07
Back
Top
